Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-018705)

Filing Details

Accession Number:: 0001209191-18-018705
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-12 08:48:55
Reporting Period:: 2018-03-08

Accepted Time:: 2018-03-12 08:48:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178253	Scynexis Inc	SCYX	Pharmaceutical Preparations (2834)	562181648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644071	David Gonzalez Angulo	101 Hudson Street, Suite 3610 Jersey City NJ 07302-6548	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-08	14,790	$1.69	88,790	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2018-03-08	11,092	$0.00	11,092	$1.85
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2018-03-08	6,655	$0.00	6,655	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,092	2018-03-08	2019-03-14	No	4	P	Direct
6,655	2018-03-08	2023-03-08	No	4	P	Direct

Footnotes

Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).